MIS Reports
Submit via DOT DAMIS at https://damis.dot.gov — MFA via Login.gov required.
| Test Category | Total Tests (excl. cancelled/blind) | Verified Negative | Verified Positive | Positive THC/Marijuana | Positive Cocaine | Positive PCP | Positive Opiates | Positive Amphetamines | Refusal — Adulterated | Refusal — Substituted | Refusal — Shy Bladder | Refusal — Other | Cancelled |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Loading... | |||||||||||||
| Test Category | Total Screening Tests | Screening Results < 0.02 | Screening Results ≥ 0.02 | Total Confirmation Tests | Confirmation Results 0.02–0.039 | Confirmation Results ≥ 0.04 | Refusal — Shy Lung | Other Refusals | Cancelled |
|---|---|---|---|---|---|---|---|---|---|
| Loading... | |||||||||
as of Dec 31 of report year
| Loading... |
| 1 | Remove | Immediately remove the employee from DOT/FAA safety-sensitive functions. |
| 2 | Initial evaluation | The SAP evaluates the employee and sends the written initial report directly to the DER. |
| 3 | Education / treatment | The employee completes the SAP's recommendations and any required continuing-care steps. |
| 4 | Follow-up evaluation | The SAP sends the written determination directly to the DER. |
| 5 | Return-to-duty test | Only after successful compliance is documented may the employer arrange the return-to-duty test. |
| 6 | Follow-up testing | All SAP-directed follow-up tests must be completed if the employee returns to safety-sensitive duty. |
Signed, dated report on the SAP's letterhead sent directly to the DER. Must contain:
- Employee's name and SSN or employee ID;
- Employer's name and address;
- Reason for assessment, DOT violation and date;
- Date(s) and format of assessment (face-to-face or remote);
- SAP's specific education and/or treatment recommendation;
- SAP's telephone number.
Ref: 49 CFR 40.293, 40.311(c)
When successful compliance is determined:
- Employee's name and SSN or employee ID;
- Employer's name and address;
- Reason for initial assessment, DOT violation and date;
- Dates and format of initial assessment + synopsis of treatment plan;
- Name of each provider that delivered education and/or treatment;
- Inclusive dates of the employee's participation;
- Clinical characterization of program participation;
- SAP's clinical determination of successful compliance;
- Written follow-up testing plan;
- Continuing-care needs;
- SAP's telephone number.
When successful compliance is NOT demonstrated:
SAP sends written notice directly to the DER. Employee must not be returned to safety-sensitive duties. Report must contain items 1–7 above plus:
- Date(s) of first follow-up evaluation;
- Date(s) of any additional follow-up evaluations;
- SAP's clinical reasons for non-compliance determination;
- SAP's telephone number.
Ref: 49 CFR 40.301, 40.311(d)–(e)
- SAP is the sole determiner of number, frequency, and type (drug/alcohol/both).
- Minimum 6 unannounced tests in the first 12 months of return.
- SAP may require additional testing for up to 48 more months.
- Employer selects dates — no discernible pattern allowed.
- Random tests cannot substitute for required follow-up tests.
- A cancelled follow-up test does not count; it must be recollected.
- Requirement follows the employee through employer changes or breaks in service.
Ref: 49 CFR 40.307, 40.309
- DER must receive the SAP's written successful-compliance report and follow-up testing plan.
- Return-to-duty test cannot occur until SAP confirms successful compliance.
- The employer — not the SAP — directs the return-to-duty test.
- Drug violation: return-to-duty drug test under direct observation, negative result required.
- Alcohol violation: return-to-duty alcohol test with result below 0.02.
- Do not confuse return-to-duty test with the SAP's follow-up testing plan.
- Meeting regulatory conditions makes the employee eligible — it does not require reinstatement.
When return-to-duty drug test may also satisfy pre-employment:
- CCF must be annotated or a statement attached explaining the dual purpose.
- Collection must be under direct observation when urine is used.
Ref: 49 CFR 40.289, 40.305, 40.309; 14 CFR 120.109(e)–(f), 120.217(e)–(f)
- SAP must send each report directly to the DER — not through a third party.
- SAP may simultaneously copy AMS Compliance as the employer's C/TPA.
- Employer must receive the report directly and ensure no third party altered it.
- Employer must retain SAP reports for 5 years from date received.
- SAP must retain copies for 5 years.
Ref: 49 CFR 40.311(a)–(b), 40.311(g)–(h)
Use before authorizing a return-to-duty test and throughout the follow-up testing period.
Regulatory references: 49 CFR Part 40, Subpart O §§ 40.289, 40.293, 40.301, 40.305, 40.307, 40.309, 40.311; 14 CFR 120.109, 120.217